APA

Llanos J., Bell C. F., Packnett E., Thiel E., Irwin D. E., Hahn B. & Ortega H. (2019). Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. : Journal of asthma and allergy.

Chicago

Llanos Jean-Pierre, Bell Christopher F, Packnett Elizabeth, Thiel Ellen, Irwin Debra E, Hahn Beth and Ortega Hector. 2019. Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. : Journal of asthma and allergy.

Harvard

Llanos J., Bell C. F., Packnett E., Thiel E., Irwin D. E., Hahn B. and Ortega H. (2019). Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. : Journal of asthma and allergy.

MLA

Llanos Jean-Pierre, Bell Christopher F, Packnett Elizabeth, Thiel Ellen, Irwin Debra E, Hahn Beth and Ortega Hector. Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study. : Journal of asthma and allergy. 2019.